CT
LMAT icon

Clearstead Trust’s LeMaitre Vascular LMAT Stock Holding History

Clearstead Trust’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-10
Closed -$876 – 1297
2025
Q3 		$876 Hold
10
– – ﹤0.01% 1252
2025
Q2 		$831 Buy
+10
New +$836 ﹤0.01% 1219

Other funds holding LMAT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.36B AUM 17.81% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $15.4B AUM 30.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Clearstead Trust's LMAT Position: Q4 2025 in Review

Clearstead Trust sold out of LeMaitre Vascular (LMAT) in Q4 2025, closing a stake of 10 shares — an estimated $876 sold.

Clearstead Trust first reported a position in LMAT in Q2 2025 and held it in 2 quarters. The position peaked at $876 in Q3 2025. 297 funds tracked by Wall St. Rank hold LMAT as of Q4 2025.

  • Clearstead Trust reported no remaining LeMaitre Vascular position as of Q4 2025 after selling out during the quarter.
  • Clearstead Trust sold 10 LeMaitre Vascular shares in Q4 2025, an estimated $876.
  • Clearstead Trust first reported a position in LeMaitre Vascular in Q2 2025 and held it in 2 quarters.
  • Clearstead Trust's LeMaitre Vascular position peaked at $876 in Q3 2025.
  • 297 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q4 2025.

Based on Clearstead Trust's 13F filing for Q4 2025, filed 9 Feb 2026.